Mayo Clinic: Preclinical Tests May Lead to New Approach to Treat CNS Lymphoma
A drug recently approved for use in multiple myeloma is now being tested for its ability to fight central nervous system (CNS) lymphoma, a deadly cancer of the immune system that can affect the brain, spinal cord and fluid, and eyes.
Source: Mayo Clinic Arizona News - Category: Hospital Management Authors: Mayo Clinic Source Type: news
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Eyes | Hospital Management | Lymphoma | Myeloma | Neurology